News

Venter's HLI nabs Millennium Health COO to oversee global expansion

J. Craig Venter's Human Longevity, Inc (HLI) has appointed a chief operating officer to manage its burgeoning genome sequencing operation. Mark Windham has taken up the position, jumping ship from drug-testing lab Millennium Health, where he also served as COO.

Biogen taps ice bucket cash to build ALS database

Biogen is working with Columbia University Medical Center to build a database of genes and clinical traits from 1,500 people with amyotrophic lateral sclerosis (ALS). The project, which is partly funded by cash raised in the Ice Bucket Challenge, is intended to help Biogen understand how genes contribute to different forms of ALS.

Life science unit graduates from Google X to become standalone business

Google has just swept aside any lingering questions about how seriously it is taking its life sciences operation. Now, instead of operating as part of the experimental Google X, life sciences is to sit alongside the legacy internet search unit as one of a clutch of businesses operating under the Alphabet umbrella.

Boehringer upgrades study startup software tool

Boehringer Ingelheim has upgraded to the latest version of InnovoCommerce's innovoPOINT.

Flatiron teams with Guardant to mine blood test data for cancer R&D

A pair of VC darlings have hooked up to speed the development of targeted cancer therapies. The deal sees Flatiron Health combine its oncology cloud system with blood test data from Guardant Health to give drug developers a platform on which they can identify molecular targets and support enrollment in clinical trials.

Intel makes pitch to become a hub for cancer data sharing

Intel has unveiled its pitch to become the organization that pulls cancer data out of silos. The semiconductor giant has spent the past two years working on the problem with Oregon Health & Science University, bringing it to the point at which it is ready to open up the platform to other organizations.

Illumina teams with VCs to place $100M bet on consumer genomics

Having played a major role in making consumer genomics feasible, Illumina is now looking to shape how the nascent sector develops. The company has teamed up with big-name VCs to create Helix, a deep-pocketed startup that is one part massive next-generation sequencing operation, one part app store for genomics.

Soon-Shiong allies with PA biomedical centers to further genomic research

Billionaire entrepreneur Patrick Soon-Shiong has teamed up with a medical center and research institute to set up a precision cancer hub. The deal connects the Big Data and immuno-oncology companies in Soon-Shiong's burgeoning NantWorks conglomerate to an emerging center of genomic research and molecular medicine in Pennsylvania.

Trader accused of using hacked newswires to make $2.3M from Dendreon implosion

On August 3, 2011, Dendreon shocked the biotech world by posting weak sales and forecasts for its cancer vaccine Provenge. The numbers blindsided investors, triggering a 64% collapse in Dendreon's share price and spreading panic through the biotech market. But, if U.S. law enforcement has it right, the news came as no surprise to one trader: Vitaly Korchevsky.

Roche rolls out smartphones for continuous monitoring of participants in Parkinson's trial

Roche is using smartphones to gather data on participants in a Parkinson's disease clinical trial between site visits. The devices will enable both active and passive data collection, with patients being asked to complete daily tests and smartphone sensors gathering information as they go about their lives.

Google hooks up with DexCom to apply miniaturized electronics to diabetes monitoring

Google has made yet another move to apply its IT wizardry to life sciences. The latest deal, which became public one day after Google unveiled its life science-motivated restructuring, sees the tech giant hook up with DexCom to marry its miniaturized electronics to diabetes sensors.

FDA adds alerts to Android drug shortages app

The latest version alerts users when new information about the shortage of a drug is available.

BioClinica makes eClinical suite available through a range of cloud options

BioClinica has expanded the range of ways customers can access its suite of eClinical tools. The new service, dubbed the BioClinica eHealth Cloud, allows biopharma companies and CROs to run Express EDC, Trident RTSM and other pieces of trial software on public, private, managed or custom cloud infrastructure.

IBM makes $1B bid for Merge to bolster Watson's image analytics capabilities

IBM has inked an agreement to buy Merge Healthcare for $1 billion. The acquisition would move its Watson computer system beyond natural language and into medical images, a field in which IBM thinks its computing power can improve the detection of changes and anomalies.

FDA picks DNAnexus for Precision Medicine genome data sharing program

The deal gives DNAnexus a starring role in the creation of precisionFDA, an open-source platform the FDA sees as a way to manage the anticipated surge in the amount of genomic data the industry has to handle.

Apple's ResearchKit goes global as heart study expands into Hong Kong and U.K.

The move marks the first time a study run using the ResearchKit platform--which made a splash earlier this year when it facilitated rapid enrollment in a handful of trials--has started accepting participants from outside the U.S.

Illumina strikes deal to buy LIMS provider GenoLogics

Illumina has struck a deal to acquire laboratory information management system player GenoLogics Life Sciences Software, ending years of speculation about the sequencing giant's interest in the business.

Teva buys majority stake in Immuneering to access genome analysis tools

Teva Pharmaceutical has bought a 51% stake in data analysis player Immuneering. The deal buys Teva the exclusive use of Immuneering's analytics tools in R&D projects involving treatments for CNS diseases.

FDA makes its first approval of a 3-D printed drug

For the first time, the FDA has approved a drug produced using a 3D printer. Aprecia Pharmaceuticals picked up the approval and distinction of being first past the post when the FDA gave the all-clear to its adjunctive therapy for the treatment of epilepsy.

First startups graduate from Illumina Accelerator as deadline for next phase nears

The first clutch of companies have graduated from Illumina Accelerator, the startup incubator program the sequencing giant set up last year. And with more than $40 million in VC cash secured to help the startups grow, Illumina is now looking for the next group of companies to join.